eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 02 2025
0mins
Source: Globenewswire
Leadership Appointment: eXoZymes Inc. has appointed Damien Perriman as Chief Commercial Officer to enhance its commercial growth, leveraging his extensive experience in biotechnology commercialization across various markets.
Innovative Biomanufacturing: The company focuses on developing AI-engineered enzymes, known as exozymes, which aim to revolutionize sustainable chemical production by overcoming limitations of traditional methods and enabling scalable biosolutions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
